Nihat Şen
Impact in
-
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Cardiovascular Function and Risk Factors 14
- Acute Myocardial Infarction Research 12
- Cardiac pacing and defibrillation studies 4
- Oncology 12
- Inflammatory Biomarkers in Disease Prognosis 12
- Co-authors
- Yusuf Tavıl (26 shared papers)Atiye Çengel (17 shared papers)Adnan Burak Akçay (30 shared papers)Mustafa Kurt (27 shared papers)M.F. Karakaş (26 shared papers)Eyüp Büyükkaya (27 shared papers)Adnan Abacı (9 shared papers)Esra Karakaş (9 shared papers)
- Journals
- Journal of Investigative Medicine (5 papers)Coronary Artery Disease (5 papers)Atherosclerosis (4 papers)Clinical and investigative medicine (4 papers)Platelets (2 papers)
- Partner nations
- TürkiyeRomaniaUnited States
In The Last Decade
Nihat Şen
82 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 75
- Cardiology and Cardiovascular Medicine 509
- Oncology 463
- Nephrology 197
- Hematology 115
- Immunology 137
Countries citing papers authored by Nihat Şen
This map shows the geographic impact of Nihat Şen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihat Şen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihat Şen more than expected).
Fields of papers citing papers by Nihat Şen
This network shows the impact of papers produced by Nihat Şen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihat Şen. The network helps show where Nihat Şen may publish in the future.
Co-authors
The 25 scholars most cited alongside Nihat Şen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 176 | |
| 2 | 2006 | 147 | |
| 3 | 2013 | 131 | |
| 4 | 2013 | 124 | |
| 5 | 2007 | 87 | |
| 6 | 2013 | 79 | |
| 7 | 2012 | 63 | |
| 8 | 2010 | 50 | |
| 9 | 2010 | 40 | |
| 10 | 2006 | 39 | |
| 11 | 2009 | 35 | |
| 12 | 2013 | 35 | |
| 13 | 2007 | 34 | |
| 14 | 2011 | 34 | |
| 15 | 2013 | 34 | |
| 16 | 2009 | 32 | |
| 17 | 2012 | 31 | |
| 18 | Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. | 2009 | 30 |
| 19 | 2011 | 28 | |
| 20 | 2013 | 28 |
About Nihat Şen
Nihat Şen is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Nephrology, Immunology and Surgery, having authored 87 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (14 papers), Inflammatory Biomarkers in Disease Prognosis (12 papers), Acute Myocardial Infarction Research (12 papers), Cardiac Imaging and Diagnostics (7 papers), Coronary Interventions and Diagnostics (7 papers), Biomarkers in Disease Mechanisms (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Cardiac pacing and defibrillation studies (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (509 citations), Oncology (463 citations), Nephrology (197 citations), Hematology (115 citations) and Immunology (137 citations). Nihat Şen has collaborated with scholars based in Türkiye, Romania and United States. Frequent co-authors include Yusuf Tavıl, Atiye Çengel, Adnan Burak Akçay, Mustafa Kurt, M.F. Karakaş, Eyüp Büyükkaya, Adnan Abacı, Esra Karakaş, İbrahi̇m Hali̇l Tanboğa and Fırat Özcan. Their work appears in journals such as Journal of Investigative Medicine, Coronary Artery Disease, Atherosclerosis, Clinical and investigative medicine and Platelets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.